BRAF and Langerhans cell histiocytosis: Recent studies have shown that somatic mutations that activate the mitogen mitogen-activated protein kinase (MAPK/ERK) pathway are detectable in most patients with Langerhans cell histiocytosis (LCH) and n-LCH, with BRAF being the most commonly mutated [10-12].